289 related articles for article (PubMed ID: 9574618)
1. Evaluation of primary pulmonary carcinoid tumors using FDG PET.
Erasmus JJ; McAdams HP; Patz EF; Coleman RE; Ahuja V; Goodman PC
AJR Am J Roentgenol; 1998 May; 170(5):1369-73. PubMed ID: 9574618
[TBL] [Abstract][Full Text] [Related]
2. The utility of fluorodeoxyglucose positron emission tomography in the evaluation of carcinoid tumors presenting as pulmonary nodules.
Daniels CE; Lowe VJ; Aubry MC; Allen MS; Jett JR
Chest; 2007 Jan; 131(1):255-60. PubMed ID: 17218584
[TBL] [Abstract][Full Text] [Related]
3. The maximum standardized uptake values on integrated FDG-PET/CT is useful in differentiating benign from malignant pulmonary nodules.
Bryant AS; Cerfolio RJ
Ann Thorac Surg; 2006 Sep; 82(3):1016-20. PubMed ID: 16928527
[TBL] [Abstract][Full Text] [Related]
4. Fluorodeoxyglucose positron emission tomography in pulmonary carcinoid tumors.
Gasparri R; Rezende GC; Fazio N; Maisonneuve P; Brambilla D; Travaini LL; Paganelli G; Petrella F; Galetta D; Spaggiari L
Q J Nucl Med Mol Imaging; 2015 Dec; 59(4):446-54. PubMed ID: 26416036
[TBL] [Abstract][Full Text] [Related]
5. Growth of a solitary pulmonary nodule after 6years diagnosed as oncocytic carcinoid tumour with a high 18-fluorodeoxyglucose (18F-FDG) uptake in positron emission tomography-computed tomography (PET-CT).
Turan O; Ozdogan O; Gurel D; Onen A; Kargi A; Sevinc C
Clin Respir J; 2013 Jan; 7(1):e1-5. PubMed ID: 22129499
[TBL] [Abstract][Full Text] [Related]
6. Use of integrated FDG PET/CT imaging in pulmonary carcinoid tumours.
Krüger S; Buck AK; Blumstein NM; Pauls S; Schelzig H; Kropf C; Schumann C; Mottaghy FM; Hombach V; Reske SN
J Intern Med; 2006 Dec; 260(6):545-50. PubMed ID: 17116005
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of occult metastatic disease in patients undergoing 18F-FDG PET for primary diagnosis or staging of lung carcinoma and solitary pulmonary nodules.
Lee ST; Berlangieri SU; Poon AM; Mitchell P; Pathmaraj K; Tabone K; Byrne AJ; O'Keefe GJ; Knight SR; Clarke CP; Scott AM
Intern Med J; 2007 Nov; 37(11):753-9. PubMed ID: 17517082
[TBL] [Abstract][Full Text] [Related]
8. A case of pulmonary typical carcinoid with an extensive oncocytic component showing intense uptake of FDG.
Kadowaki T; Yano S; Araki K; Tokushima T; Morioka N
Thorax; 2011 Apr; 66(4):361-2. PubMed ID: 21075777
[No Abstract] [Full Text] [Related]
9. Differentiating benign from malignant lung lesions using "quantitative" parameters of FDG PET images.
Hübner KF; Buonocore E; Gould HR; Thie J; Smith GT; Stephens S; Dickey J
Clin Nucl Med; 1996 Dec; 21(12):941-9. PubMed ID: 8957608
[TBL] [Abstract][Full Text] [Related]
10. The utility of the nonattenuation corrected 18F-FDG PET images in the characterization of solitary pulmonary lesions.
Huang YE; Pu YL; Huang YJ; Chen CF; Pu QH; Konda SD; Appelbaum DE
Nucl Med Commun; 2010 Nov; 31(11):945-51. PubMed ID: 20739905
[TBL] [Abstract][Full Text] [Related]
11. Marked 18-Fuorine-Fluorodeoxyglucose (FDG) Avidity of an Intrapulmonary Typical Carcinoid Tumor Manifesting as a Bronchocele in an Asymptomatic Middle-Aged Woman.
Saadé-Yordán C; McBurney-Henriquez E; González-Santoni R; Gurrea-Rosas C; Montalvo-Fitzpatrick J; Maldonado-Vargas JA
Am J Case Rep; 2017 Dec; 18():1390-1395. PubMed ID: 29282351
[TBL] [Abstract][Full Text] [Related]
12. Better discrimination of the nature of the synchronous pulmonary nodules with different morpho-metabolic characteristics by
Garcia JR; Alvarez-Moro FJ; Soler M; Mourelo S; Bassa P; Riera E
Rev Esp Med Nucl Imagen Mol (Engl Ed); 2020; 39(2):110-111. PubMed ID: 31918977
[No Abstract] [Full Text] [Related]
13. CT features of peripheral pulmonary carcinoid tumors.
Meisinger QC; Klein JS; Butnor KJ; Gentchos G; Leavitt BJ
AJR Am J Roentgenol; 2011 Nov; 197(5):1073-80. PubMed ID: 22021498
[TBL] [Abstract][Full Text] [Related]
14. Multimodality imaging features in a case of bronchial carcinoid including FDG PET.
Shin V; Bhargava P; Brown J; Ames ED; Kang P
Med Sci Monit; 2007 Jan; 13(1):CS4-8. PubMed ID: 17179913
[TBL] [Abstract][Full Text] [Related]
15. Are the 18F-FDG positron emission tomography/computed tomography findings in bronchopulmonary carcinoid tumors different than expected?
Alpay L; Lacin T; Kanbur S; Kiral H; Ersoz E; Bayram S; Dogruyol T; Baysungur V; Yalcinkaya I
Hell J Nucl Med; 2013; 16(3):213-7. PubMed ID: 24251310
[TBL] [Abstract][Full Text] [Related]
16. FDG-PET imaging in patients with pulmonary carcinoid tumor.
Moore W; Freiberg E; Bishawi M; Halbreiner MS; Matthews R; Baram D; Bilfinger TV
Clin Nucl Med; 2013 Jul; 38(7):501-5. PubMed ID: 23486331
[TBL] [Abstract][Full Text] [Related]
17. Detection of primary and recurrent lung cancer by means of F-18 fluorodeoxyglucose positron emission tomography (FDG PET).
Duhaylongsod FG; Lowe VJ; Patz EF; Vaughn AL; Coleman RE; Wolfe WG
J Thorac Cardiovasc Surg; 1995 Jul; 110(1):130-9; discussion 139-40. PubMed ID: 7609536
[TBL] [Abstract][Full Text] [Related]
18. Controlled prospective study of positron emission tomography using the glucose analogue [18f]fluorodeoxyglucose in the evaluation of pulmonary nodules.
Präuer HW; Weber WA; Römer W; Treumann T; Ziegler SI; Schwaiger M
Br J Surg; 1998 Nov; 85(11):1506-11. PubMed ID: 9823912
[TBL] [Abstract][Full Text] [Related]
19. FDG uptake heterogeneity evaluated by fractal analysis improves the differential diagnosis of pulmonary nodules.
Miwa K; Inubushi M; Wagatsuma K; Nagao M; Murata T; Koyama M; Koizumi M; Sasaki M
Eur J Radiol; 2014 Apr; 83(4):715-9. PubMed ID: 24418285
[TBL] [Abstract][Full Text] [Related]
20. Correlation between 18F-FDG uptake on PET and molecular biology in metastatic pulmonary tumors.
Kaira K; Okumura T; Ohde Y; Takahashi T; Murakami H; Oriuchi N; Endo M; Kondo H; Nakajima T; Yamamoto N
J Nucl Med; 2011 May; 52(5):705-11. PubMed ID: 21498541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
